PRNIX | VMVAX | PRNIX / VMVAX | |
Total Expense Ratio | 0.65 | 0.07 | 929% |
Annual Report Gross Expense Ratio | 0.83 | 0.07 | 1,186% |
Fund Existence | 28 years | 14 years | - |
Gain YTD | 3.076 | 5.592 | 55% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 587M | 31B | 2% |
Annual Yield % from dividends | 1.76 | 2.22 | 79% |
Returns for 1 year | 4.04 | 8.08 | 50% |
Returns for 3 years | -15.15 | 17.95 | -84% |
Returns for 5 years | 5.11 | 65.77 | 8% |
Returns for 10 years | 17.41 | 88.57 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDIV | 39.06 | 0.14 | +0.36% |
SPDR® S&P Emerging Markets Dividend ETF | |||
FCEF | 22.61 | 0.04 | +0.16% |
First Trust Income Opportunity ETF | |||
GDIV | 15.76 | N/A | +0.02% |
Harbor Dividend Growth Leaders ETF | |||
RND | 28.10 | -0.06 | -0.20% |
First Trust Bloomberg R&D Leaders ETF | |||
VV | 297.02 | -0.64 | -0.22% |
Vanguard Large-Cap ETF |